Literature DB >> 23115971

[Microbial conversion of daidzein affects fecal equol concentration and bacterial composition of rats with or without ovariectomy].

Xun Zhang1, Weijiang Zheng, Shana Huang, Wen Yao.   

Abstract

UNLABELLED: Equol is the end metabolite of daidzein by certain intestinal bacteria, which has stronger bioactivity comparing with daidzein.
OBJECTIVE: To evaluate the role of orally administrated equol-producing bacterium on increasing equol production and shifting intestinal microbiota of embracer animal.
METHODS: In total 60 rats with or without ovariectomy at average bodyweight 211 +/- 9g were divided into 5 groups. The differences on equol concentration and bacterial composition were compared in rats orally treated with distilled water, estradiol, daidzein, equol and daidzein + ZX7.
RESULTS: The fecal equol concentration in daidzein groups was significantly higher than that in control and estradiol groups. The fecal equol concentration in daidzein + ZX7 groups was comparable to that in equol groups. Principal Components Analysis (PCA) of fecal DGGE profiles showed clear difference of fecal microbiota between ovariectomy done or undone rats. Fecal population of Bacteriodetes showed strong correlation with fecal equol concentration.
CONCLUSION: Normal intestinal microbiota in rats might have the capacity to convert daidzein into equol. Dietary source of equol-producing bacterium ZX7 might have the possibility to increase the equol production of embracer animal. Endogenous estrogen concentration might shift the intestinal microbiota on rats. Bacteriodetes might have an important role on equol production.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115971

Source DB:  PubMed          Journal:  Wei Sheng Wu Xue Bao        ISSN: 0001-6209


  3 in total

1.  Lactulose increases equol production and improves liver antioxidant status in barrows treated with Daidzein.

Authors:  Weijiang Zheng; Yanjun Hou; Wen Yao
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

2.  Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions.

Authors:  Lorenzo Polimeno; Michele Barone; Adriana Mosca; Maria Teresa Viggiani; Farahnaz Joukar; Fariborz Mansour-Ghanaei; Sara Mavaddati; Antonella Daniele; Lucantonio Debellis; Massimo Bilancia; Luigi Santacroce; Alfredo Di Leo
Journal:  Microorganisms       Date:  2020-03-25

3.  Gut metabolite S-equol ameliorates hyperexcitability in entorhinal cortex neurons following Theiler murine encephalomyelitis virus-induced acute seizures.

Authors:  Allison Gallucci; Dipan C Patel; K'Ehleyr Thai; Jonathan Trinh; Rosalie Gude; Devika Shukla; Susan L Campbell
Journal:  Epilepsia       Date:  2021-07-02       Impact factor: 6.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.